HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Oncostatin M

A cytokine with both pro- and anti-inflammatory actions that depend upon the cellular microenvironment. Oncostatin M is a 28 kDa monomeric glycoprotein that is similar in structure to LEUKEMIA INHIBITORY FACTOR. Its name derives from the the observation that it inhibited the growth of tumor cells and augmented the growth of normal fibroblasts.
Networked: 375 relevant articles (4 outcomes, 40 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Richards, Carl D: 13 articles (09/2014 - 05/2002)
2. Blanchard, Frédéric: 7 articles (11/2012 - 12/2003)
3. Tanaka, Minoru: 5 articles (08/2015 - 08/2008)
4. Jorcyk, Cheryl L: 5 articles (03/2015 - 01/2004)
5. Heymann, Dominique: 5 articles (11/2012 - 11/2004)
6. Miyajima, Atsushi: 4 articles (08/2015 - 08/2008)
7. Ryan, Randall E: 4 articles (03/2015 - 01/2004)
8. Kaun, Christoph: 4 articles (10/2011 - 03/2008)
9. Rega, Gersina: 4 articles (10/2011 - 03/2008)
10. Wojta, Johann: 4 articles (10/2011 - 03/2008)

Related Diseases

1. Neoplasms (Cancer)
2. Breast Neoplasms (Breast Cancer)
3. Lung Neoplasms (Lung Cancer)
4. Anoxia (Hypoxia)
5. Myocardial Infarction

Related Drugs and Biologics

1. Cytokines
2. bevacizumab
3. Interleukin-6 (Interleukin 6)
4. Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
5. Leukemia Inhibitory Factor
6. Carbon Monoxide
7. Interleukin-1alpha (Interleukin 1 alpha)
8. Interleukin-11 (Interleukin 11)
9. Ciliary Neurotrophic Factor (CNTF)
10. Interleukins

Related Therapies and Procedures

1. Heterologous Transplantation (Xenotransplantation)
2. Root Planing
3. Transplantation (Transplant Recipients)
4. Angioplasty (Angioplasty, Transluminal)
5. Therapeutics